IBANDRONAT Mepha 150 mg comprimés mensuels 3 pce

7680613170043 CH-61317 M05BA06 07.99.0.

Active substances:

IBANDRONAT Mepha 150 mg comprimés mensuels 3 pce
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6131701
CPT
-
Packaging group
3
Unit
Tablette(n)
Composition
acidum ibandronicum 150 mg ut natrii ibandronas monohydricus, cellulosum microcristallinum, povidonum, crospovidonum, silica colloidalis anhydrica, acidum stearicum, Überzug: E 171, hypromellosum, macrogolum 400, polysorbatum 80, pro compresso obducto corresp. natrium 10.8 mg.

Articles (1)

Ibandronat-Mepha 150 mg Monatstabletten, Filmtabletten
Filmtabletten
3
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
06/08/2026
Professional SmPC
Français
06/08/2026
Professional SmPC
Italien
06/08/2026
Patient information leaflet
Allemand
05/08/2026
Patient information leaflet
Français
05/08/2026
Patient information leaflet
Italien
05/08/2026

Detailed composition

Substance Quantity Type Category
acidum ibandronicum
150.0 MG Substance Wirkstoff (Principe actif)
natrii ibandronas monohydricus
- Substance WIZUS
cellulosum microcristallinum
- Substance HNIDK
povidonum
- Substance HNIDK
crospovidonum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
acidum stearicum
- Substance HNIDK
E 171
- Substance FNIDK
hypromellosum
- Substance HNIDK
macrogolum 400
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
polysorbatum 80
- Substance HNIDK
natrium
10.8 MG Substance HBESI

Reimbursement information

Public price
CHF 62.50
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/07/2012

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
61317
Drug name
Ibandronat-Mepha 150 mg Monatstabletten, Filmtabletten
Galenic form
FILM
ATC Code
M05BA06
Authorization status
Z
Dispensation category
B
First authorization
24/02/2011
Authorization expiration date
31/12/9999
IT number
07.99.0.
Domain
Human medicine
Field of application
Osteoporose

Packaging details

Description (FR)
IBANDRONAT Mepha 150 mg comprimés mensuels 3 pce
Description (DE)
IBANDRONAT Mepha 150 mg Monatstabletten 3 Stk
Market launch
24/02/2011
Narcotic (BTM)
No

Original drug

Bondronat 6 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung
CHF 210.75
View original

Other packaging sizes

IBANDRONAT Mepha 150 mg comprimés mensuels
1 TABL
View
Buy us a coffee Explore the data